William Ashton - 17 Jun 2021 Form 4 Insider Report for SPECTRUM PHARMACEUTICALS INC (SPPI)

Role
Director
Signature
/s/ Kurt A. Gustafson, attorney-in-fact for William L. Ashton
Issuer symbol
SPPI
Transactions as of
17 Jun 2021
Transactions value $
-$38,160
Form type
4
Filing time
22 Jun 2021, 16:51:32 UTC
Previous filing
17 May 2021
Next filing
20 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SPPI Common Stock, $0.001 par value Award $0 +14,277 +34% $0 55,943 17 Jun 2021 Direct F1
transaction SPPI Common Stock, $0.001 par value Sale -$38,160 -9,000 -16% $4.24 46,943 18 Jun 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SPPI Stock Option (Right to Buy) Award $0 +67,804 $0 67,804 17 Jun 2021 Common Stock 67,804 $4.29 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 100% of the restricted shares shall vest on the earlier of (1) June 17, 2022 or (2) the date of the company's 2022 Annual Meeting of Stockholders.
F2 All sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person for the purpose of satisfying tax withholding obligations in connection with restricted stock awards granted by the issuer.
F3 One third of the aggregate amount of option shares shall vest on each of June 17, 2022, 2023 and 2024, respectively.